Sertraline + Placebo
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Phobia, Social
Conditions
Phobia, Social, Panic Disorder, Agoraphobia, Obsessive-Compulsive Disorder, Anxiety Disorders, Major Depressive Disorder
Trial Timeline
Jul 1, 2002 → Jan 1, 2018
NCT ID
NCT00182533About Sertraline + Placebo
Sertraline + Placebo is a approved stage product being developed by Pfizer for Phobia, Social. The current trial status is terminated. This product is registered under clinical trial identifier NCT00182533. Target conditions include Phobia, Social, Panic Disorder, Agoraphobia.
What happened to similar drugs?
1 of 1 similar drugs in Phobia, Social were approved
Approved (1) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00406952 | Pre-clinical | Completed |
| NCT00182533 | Approved | Terminated |
| NCT01114100 | Approved | Completed |
Competing Products
4 competing products in Phobia, Social
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| LY686017 + paroxetine + placebo | Eli Lilly | Phase 2 | 35 |
| atomoxetine + placebo | Eli Lilly | Phase 2/3 | 38 |
| Quetiapine XR | AstraZeneca | Phase 2 | 35 |
| quetiapine | AstraZeneca | Approved | 43 |